Immunogenicity of rat hepatoma membrane fractions
- PMID: 4357132
- PMCID: PMC2008927
- DOI: 10.1038/bjc.1973.164
Immunogenicity of rat hepatoma membrane fractions
Abstract
The principal expression of immunity elicited in syngeneic rats immunized with rat hepatoma membrane fractions was the development of a tumour specific antibody response. This antibody was demonstrable by membrane immunofluorescence staining of viable hepatoma cells in suspension and the sera exhibited complement dependent cytotoxicity for cultured hepatoma cells. In the absence of complement, however, membrane immune sera were highly "blocking", protecting plated hepatoma cells from attack by sensitized lymph node cells. The cell mediated immune response elicited by hepatoma membrane immunization was weak, as evaluated by the colony inhibitory activity of lymph node cells for hepatoma cells in vitro or the adoptive transfer of immunity with peritoneal exudate cells. Correlated with this overall pattern of immune response, membrane immunization did not elicit tumour rejection reactions. These findings are relevant to current views that humoral factors operate antagonistically to limit cell mediated immunity to tumours. A further relevant feature was the observation that membrane immunization, eliciting a prominent humoral immune reaction, conditioned the recipients so that they subsequently failed to elicit a tumour rejection immunity on treatment with irradiated tumour cells.
Similar articles
-
Immunogenic properties of rat hepatoma subcellular fractions.Br J Cancer. 1974 Nov;30(5):394-400. doi: 10.1038/bjc.1974.213. Br J Cancer. 1974. PMID: 4377707 Free PMC article.
-
Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.Int J Cancer. 1974 Nov 15;14(5):589-97. doi: 10.1002/ijc.2910140505. Int J Cancer. 1974. PMID: 4376528 No abstract available.
-
Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.Int J Cancer. 1975 Apr 15;15(4):640-50. doi: 10.1002/ijc.2910150413. Int J Cancer. 1975. PMID: 166943
-
Membrane associated antigens in chemically-induced tumours.Ser Haematol. 1972;5(4):67-92. Ser Haematol. 1972. PMID: 4133764 Review. No abstract available.
-
Tumour-associated antigens and tumour-host interactions.Proc R Soc Med. 1971 Oct;64(10):1039-42. doi: 10.1177/003591577106401013. Proc R Soc Med. 1971. PMID: 4335921 Free PMC article. Review. No abstract available.
Cited by
-
Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.Br J Cancer. 1974 Nov;30(5):382-93. doi: 10.1038/bjc.1974.212. Br J Cancer. 1974. PMID: 4143271 Free PMC article.
-
Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours.Br J Cancer. 1974 Jan;29(1):1-10. doi: 10.1038/bjc.1974.1. Br J Cancer. 1974. PMID: 4362448 Free PMC article.
-
Specific immunoprophylaxis in experimental tumour-host systems.Can Med Assoc J. 1980 Apr 5;122(7):780-4. Can Med Assoc J. 1980. PMID: 7363246 Free PMC article.
-
Immunogenicity of cellular and acellular antigen preparations from a methylcholanthrene-induced mouse sarcoma.J Cancer Res Clin Oncol. 1982;104(3):237-47. doi: 10.1007/BF00406244. J Cancer Res Clin Oncol. 1982. PMID: 6761343 Free PMC article.
-
The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice.Br J Cancer. 1974 Oct;30(4):289-96. doi: 10.1038/bjc.1974.195. Br J Cancer. 1974. PMID: 4447774 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources